ABBOTT LABORATORIES — Director's Dealing 2017

Feb 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-02-17

Reporting Person: BIRD ROGER (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-17	Common shares without par value	A	13307	—	Acquired	63910	Direct
2017-02-21	Common shares without par value	F	727	$44.69	Disposed	63183	Direct
2017-02-21	Common shares without par value	S	219	$44.910	Disposed	62964	Direct
2017-02-21	Common shares without par value	S	100	$44.995	Disposed	62864	Direct
2017-02-22	Common shares without par value	M	11030	$26.6973	Acquired	73894	Direct
2017-02-22	Common shares without par value	M	1873	$26.1976	Acquired	75767	Direct
2017-02-22	Common shares without par value	S	9936	$45.02	Disposed	65831	Direct
2017-02-22	Common shares without par value	S	700	$45.03	Disposed	65131	Direct
2017-02-22	Common shares without par value	S	100	$45.031	Disposed	65031	Direct
2017-02-22	Common shares without par value	S	1500	$45.035	Disposed	63531	Direct
2017-02-22	Common shares without par value	S	400	$45.04	Disposed	63131	Direct
2017-02-22	Common shares without par value	S	100	$45.041	Disposed	63031	Direct
2017-02-22	Common shares without par value	S	167	$45.045	Disposed	62864	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-17	Option (right to buy)	$44.40	A	92032	Acquired	2027-02-16	Common shares (92032)	Direct
2017-02-22	Option (right to buy)	$26.6973	M	11030	Disposed	2018-02-14	Common shares (11030)	Direct
2017-02-22	Option (right to buy)	$26.1976	M	1873	Disposed	2018-03-30	Common shares (1873)	Direct

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 30,678 on 02/17/2018, 30,677 on 02/17/2019, and 30,677 on 02/17/2020.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.